ES296176A1 - A new compound of hydrogiretinic acid of drug activity and its manufacturing procedure (Machine-translation by Google Translate, not legally binding)
- Google Patents
A new compound of hydrogiretinic acid of drug activity and its manufacturing procedure (Machine-translation by Google Translate, not legally binding)
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ferrer Internacional SA
Original Assignee
Laboratorios Ferrer SL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Ferrer SLfiledCriticalLaboratorios Ferrer SL
Priority to ES0296176ApriorityCriticalpatent/ES296176A1/en
Publication of ES296176A1publicationCriticalpatent/ES296176A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Steroid Compounds
(AREA)
Abstract
A new compound of glycyrrhetinic acid of medicinal activity and its manufacturing process which is mainly characterized in reacting under certain conditions the glycyrrhetinic acid or some of its soluble derivatives, preferably an ester with a solution containing a monovalent base and subsequently with a solution water containing the stoichiometric amount of aluminum ion to obtain a product whose formula developed is ** (See formula) ** and with a molecular weight of 1436.05. (Machine-translation by Google Translate, not legally binding)
ES0296176A1964-02-061964-02-06A new compound of hydrogiretinic acid of drug activity and its manufacturing procedure (Machine-translation by Google Translate, not legally binding)
ExpiredES296176A1
(en)
Procedure for the preparation of N-ethyl-2-pirrolylllymehyl-2-metoxy-5-etisulfonyl-benzamide. (Machine-translation by Google Translate, not legally binding)